Visit the original URL
36 Krypton learned that Boston Scientific Corporation and Acotec Medical Technology Holdings Co., Ltd. announced that Boston Scientific will launch a partial offer to acquire a majority stake of up to 65% of Aotec’s shares. The proposed price of the transaction is HK$20 per share, which translates to approximately US$523 million in cash for a 65% stake at current exchange rates. Boston Scientific does not expect the transaction to have a material impact on adjusted earnings per share in 2023. The transaction is expected to be completed in the first half of 2023, depending on the degree of acceptance and approval of the offer by Aotena shareholders, as well as other conditions specified in the relevant documents.
media reports
Sina 36Kr titanium media
This article is transferred from: https://readhub.cn/topic/8lGbidHrwp2
This site is only for collection, and the copyright belongs to the original author.